Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Description
Revolutionizing the way heart failure is identified, the EchoGo Heart Failure platform leverages artificial intelligence to enhance precision in detecting HFpEF from echocardiograms. Developed in partnership with the Mayo Clinic, this innovative solution simplifies the detection process, achieving remarkable accuracy from just a single apical 4-chamber view, addressing the challenges that have long hindered identification of this condition. As the first AI-driven platform dedicated to HFpEF detection in echocardiography, Ultromics sets the standard in this field, making it a leader in the use of AI for cardiac imaging. Our advanced technology not only allows for earlier and more efficient identification of heart failure but also aims to improve the overall quality of life for patients. Through our user-friendly and secure cloud-based Software-as-a-Service (SaaS) platform, Ultromics seamlessly integrates with existing echocardiography systems, providing labs with the tools necessary for precise heart failure detection and effective risk stratification. This capability has the potential to significantly lower hospitalization rates related to heart failure, ultimately benefiting healthcare systems and patients alike. As we continue to innovate, our commitment remains to transform cardiac care for the better.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
BenevolentAI
Founded
2013
Country
Luxembourg
Website
www.benevolent.com
Vendor Details
Company Name
Ultromics
Country
United Kingdom
Website
www.ultromics.com
Product Features
Product Features
Medical Imaging
Automated Routing
Comparison View
Compliance Management
Data Import / Export
Diagnostic Reporting
Image Analytics
Treatment Planning
Workflow Management